Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
Developed by Zoetis, Apoquel is the first Janus kinase (JAK) inhibitor approved for veterinary use. The company says it inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies.
Michael Stegemann, Senior Director Global Development Organisation at Zoetis said: "Apoquel is a targeted treatment that specifically inhibits JAK-dependent cytokines involved in allergic skin disease in dogs. Its rapid anti-pruritic effect along with its anti-inflammatory properties provide fast relief to dogs. Relief from itch and inflammation is maintained in dogs receiving long-term treatment with Apoquel. This exciting innovation molecule offers quick, effective, and sustained itch relief; improves skin lesions continuously and can be used safely short or long-term."
Zoetis says that in clinical trials, Apoquel demonstrated safety and efficacy for the treatment of itch and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners as soon as 24 hours after administration, the first observation time point, and itch continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinary surgeons were significantly improved after one week and continued to improve long term during the studies (4 months). In these studies, the most common side effects observed in dogs treated with Apoquel were vomiting and diarrhea. Other reported side effects included lethargy, decreased or lack of appetite, skin irritation or infection, and ear irritation or infection.
Apoquel will be a POM-V treatment. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium to long term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Zoetis plans to make Apoquel available to veterinary surgeons in the European Union during 2014. Meantime, Zoetis says it will be working with vets on the new science and research findings around itch and canine allergic diseases. For more information, visit www.zoetis.com, www.itchcycle.com.
The new app has been specifically developed for CVS, is unique to the group, and is owned by the company.
It is powered by LocumBell technology.
When registering on the app, locums can input their work preferences - including their skills, desired travel radius and preferred shift times - so that they are only served up shift advertisements relevant to them.
Users can also set up notifications for upcoming jobs.
The app then allows locums to set minimum shift rates, submit the rate they would like to receive for a shift and negotiate their fees directly with a practice.
Shifts can be then be booked or cancelled on the app at the touch of a button.
All upcoming booked shifts appear on the users’ calendar.
Once a shift has been completed, locums can submit the invoice for their work using the app.
The app allows locums to see every CVS practice invoice and its status, which CVS says will allow queries to be resolved quicker and payments issued faster.
The app is being rolled out to all of CVS's practices from this August.
Amy Hughes, Head of Recruitment at CVS, said: “Locum administration can be time-consuming – as locums first have to identify work, liaise with a practice and our central support team, to negotiate and book a shift, then complete all invoice paperwork.
"We wanted to remove that pain and make it easier for locums to work with us.
The app is available for Apple devices on the App Store and for Android devices on the Play Store.
For any technical difficulties or assistance, contact: support@locumbell.com or call 0161 556 7685.
Kruuse UK has announced the launch of its new Mud Fever Kits for horses.
Kruuse says the launch follows independent studies last year by Aimi Duff BVM&S, MRCVS (Scott, Mitchell & Associates, Hexham) on the use of Manuka ND dressings for the treatment of Mud Fever.
The kit contains one complete treatment for two legs (or two complete treatments for one leg) including all dressings. There is also a step-by-step guide from the "Ask the Vet" series which explains best treatment protocol, designed to help veterinary surgeons dispense the kit directly to clients with confidence.
According to the company, the benefits of using medical grade Manuka Honey in the treatment of Mud Fever include:
Andrew Groom, Managing Director of Kruuse UK Ltd said: "We are delighted with the initial response to our unique Mud Fever Kits; such additions to our range continue to enhance the Kruuse commitment to equine wound care."
RSPCA Chief Veterinary Officer, Caroline Allen, today praised the vets and nurses who are providing essential care to animals through the crisis.
She said: “This is an incredibly challenging time for the RSPCA, trying to advise the public and keeping emergency services going with fewer staff, strained resources and in line with Government advice.
"I know this is equally stressful and challenging for vet staff too and I wanted to say a huge thank you from everyone at the RSPCA for your hard work, dedication and support you are giving the RSPCA.
"Our call centre team and officer are working hard to maintain a frontline animal welfare service, but we know there may be occasions where we are unable to attend and this may impact demand on the local vet practice."
Current guidance from the BVA defines emergency and urgent treatment as:
Caroline continued: "There are some circumstances particular to the RSPCA, such as animals that have been subject to abuse or severe neglect, or injured/unwell unowned animals, that may not initially appear to be such an “emergency” in the traditional sense, but our officers will only be collecting them if there is considered to be ‘significant impact on health/welfare and likely to deteriorate if left unmanaged’ as covered by the BVA emergency criteria. We would greatly appreciate your support in ensuring we can protect the welfare of these animals.
"Our National Control Centre will also be following the guidance from the BVA and will be limiting, wherever possible, sending members of the public to vets. However, on occasions where there is a welfare need that would justify an essential journey, we will always ask members of the public to call practices first and follow their social distancing protocols.
"For vets who provide care for our shelters and private boarders we understand the support available will be limited, we will be producing further advice for our teams around options, including remote support.
"We do understand and appreciate the current restrictions being put in place by the BVA and we do understand the very serious strain on practices and teams at this time and we hope that we can continue to work together during this unprecedented time."
Fort Dodge has announced that a challenge study has demonstrated the ability of Duvaxyn® IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Sydney/07 (H3N8) two weeks after a two dose primary course. This strain was responsible for the financially devastating equine influenza outbreak in Australia in August 2007.
Duvaxyn IE-T Plus is an inactivated whole virus equine influenza vaccine, adjuvanted with an aqueous-based adjuvant. According to Fort Dodge, experts at a recent WHO meeting on human vaccines expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins in the vaccine*.
The study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two dose of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Sydney/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Helen Barnes, EMEA Equine Business Manager for Fort Dodge, said: "The results of this challenge study provide reassurance for owners that horses vaccinated with Duvaxyn will be protected against circulating strains of equine influenza, including the Sydney strain which proved so damaging.
"As the benefits offered by whole virus technology are increasingly recognised, the popularity of vaccines based on this technology is re-emerging, particularly to combat a potential pandemic.
"The entire Duvaxyn range of equine vaccines, including the recently licensed Duvaxyn WNV for West Nile Virus, are based on the whole virus approach as we believe it offers a broad and consistent level of protection."
The RCVS has introduced a new online recording system for graduates starting their Professional Development Phase (PDP).
The new PDP database sits as a module within the Professional Development Record (PDR), launched by the RCVS in April to help veterinary surgeons and veterinary nurses plan, evaluate and record their CPD.
Freda Andrews, RCVS Head of Education said: "Bringing the PDP into the new Professional Development Record shows clearly how this stage of a vet's development is part of the continuum of professional development that starts at university and continues for as long as they practise. We are also developing a system for students to record their practical and clinical experience whilst at university and, once this is complete next year, the PDR will become a complete record of professional lifelong learning."
Like the rest of the PDR, the new PDP module offers extra space for notes, and allows documents such as case reports and presentations to be uploaded and stored. Responding to feedback from users of the old PDP system, the new interface is designed to be more user friendly than the previous PDP database, and contains interactive help, guidance on PDP and an easier means of recording case numbers against the clinical skills lists. All new graduates from 2012 are able to sign up to use the new PDP site and, once their account is activated, they will also be able to use the CPD area to record any additional CPD they might undertake.
Graduates from previous years who are still undertaking their PDP using the old database may continue on the old system for the time being, although at some stage within the next year or so, the old site will need to be archived. Anyone who would prefer to use the new system instead should contact the PDP administrator at the RCVS to discussed transferring (pdp@rcvs.org.uk 020 7202 0736). As the skills lists have changed slightly, however, an automatic transfer of data from the old to the new isn't possible.
The PDP links the 'Day One' competences that veterinary surgeons have achieved when they graduate to the 'Year One' competences which they are expected to have achieved after about a year in practice. Each vet's progress through the PDP is supervised by a Postgraduate Dean, and its completion also requires sign-off from the veterinary surgeon's employer or mentor.
For more information, or to sign up to the PDP, visit www.rcvs.org.uk/pdp.
The British Safety Council has launched a new qualification to help people who drive as part of their work stay safe on the roads.
According to the organisation, the Level 2 Award in Safe Driving at Work provides work drivers with key knowledge of the hazards and risks associated with driving and equips them with valuable guidance on the measures available for reducing these risks, such as vehicle inspection, behaviour and defensive driving.
According to estimates from the Health and Safety Executive (HSE), up to a third of all road traffic accidents in Britain involve someone involved in work-related activity. In 2013, according to government figures, 1,713 people died on the road, with the total number of casualties standing at 183,670.
The Ofqual-regulated qualification, which is designed to be delivered by employers or training organisations, instructs learners on a range of topics including the particular risks associated with vulnerable road users, such as cyclists and pedestrians, the importance of regular vehicle safety checks and how to adapt driving style in response to changes in driving conditions or the actions of others.
Alex Botha, the British Safety Council's Chief Executive, said: "Driving can be a risky activity, a fact borne out by the high number of injuries and fatalities that occur annually on our roads.
"However, simple steps can be taken by employers and drivers to manage and reduce this risk. Our new Level 2 Award in Safe Driving at Work provides learners with all the essential knowledge to help them stay safe on the roads.
"Learners can expect to leave the qualification with a thorough knowledge of the main risks posed by driving - whether to themselves or other road users - and how to reduce them.
"Once registered with us, employers or training centres deliver the training using the high-quality teaching and student materials provided. Qualifications are assessed through a 45-minute multiple-choice examination that can be either taken online or on paper.
"This is a stand-alone qualification designed for delivery as a short course. It is also well-suited for integration into wider vocational programmes of study or, for example, as part of an induction programme. Students need no former knowledge or experience, so can come from a diverse range of educational and employment backgrounds.
"Safer driving habits should also feed through into workers' personal lives, providing employers with a valuable corporate social responsibility tool to help make our roads safer in and out of work."
Avishield IB G1-13 is indicated for active immunisation of chicks to reduce the adverse effect on cilia caused by infectious bronchitis.
The vaccine is one of two targeting the IBV 793B serotype and, with the addition of this new claim, Avishield can now be administrated on broiler, broiler breeder and laying hen farms.
Avishield IB GI-13 is a lyophilisate for oculonasal suspension/use in drinking water which contains live avian infectious bronchitis virus variant strain V-173/11: 102.7-104.6 EID50.
It has an onset of immunity 10 days after vaccination and a duration of immunity of 56 days.
Johnny Wells West, poultry key account manager at Dechra Veterinary Products, said: “The new licence extension for Avishield IB G1-13 allows greater flexibility for poultry producers to protect their flocks against infectious bronchitis on broiler, broiler breeder and laying hen farms and it is welcome news for both Dechra and the poultry industry.”
For more information contact Johnny Wells West on 07584 175758 or visit http://www.dechra.co.uk/Avishield IB G1-13
The Guardian has published it's University Guide 2014, which ranks Cambridge as the best vet school, and Bristol as the worst.
Universities were ranked by the Guardian according to a number of criteria, including what percentage of students are satisfied with the course, the student:staff ratio and the amount spent per student.
The full league table of universities (with their Guardian scores in brackets) was:
Interestingly, though, only 76% of Cambridge students are in graduate level jobs, or studying further, within six months of graduation, compared to Glasgow's 95%. Meanwhile, Nottingham had the highest percentage of students that were satisfied with the course and the teaching. Liverpool had the highest spend per student, and Cambridge had the lowest student:staff ratio.
Zoetis has announced the introduction of Equimidine solution in a 50% larger plastic bottle.
The company says the new 15ml multi-dose presentation, now in plastic rather than glass, offers greater safety, as well as cost-saving advantages to practices.
Equimidine, containing 10mg/ml detomidine hydrochloride and methyl parahydroxybenzoate 1 mg/ml as a preservative, is a clear solution for intravenous injection. It has sedative and analgesic properties and is indicated for use either alone or in combination with butorphanol to facilitate the handling of horses for clinical examinations, minor surgical procedures and other manipulations. It can also be used with ketamine for short duration general anaesthesia for surgical procedures such as castration.
According to the company, the new 15ml plastic bottle is more cost-effective per dose than the old 10ml glass vial. It is also safer to use as the bottle is less likely to break if accidentally dropped. The multi-dose facility involves a tightly fitted rubber bung through which a sterile needle can be inserted to withdraw each dose.
Penny McCann, Equine Product Manager, Zoetis UK Ltd, said: "The new presentation provides practical benefits for vets and the larger bottle size means the product is now even more cost-effective."
For more information, speak to your Zoetis Account Manager, refer to the SPC or contact Zoetis Customer Support on 0845 3008034.
The kit uses an indirect semi-quantitative IgG antibody assay which provides an easy-to-read colour change which clearly distinguishes normal IgG levels (>8mg/ml; colourless), partial FPT (4-8mg/ml; pink) and levels generally considered diagnostic of complete FPT (<4mg/ml; purple).
Vetlabs says the kit has a proven sensitivity and specificity of 97.4% and 93.6% respectively, and responds equally well with anticoagulant whole blood, serum or plasma. And with no additional equipment or refrigerated storage required, it is a true field test.
Mike Fleming, CEO of Vetlab Supplies Ltd said: "It’s not often you get to launch an equine diagnostic that’s genuinely life saving. With Fastest IgG Equine, vets can now give a clear-cut Failure of Passive Transfer (FPT) diagnosis at farms, stables or equestrian centres – and all in just 10 minutes."
According to the company, as many as 1 in 5 new-born foals can suffer some degree of IgG FPT. Foals with no antibody protection, due to complete FTP, have an estimated 75% chance of contracting debilitating or life-threatening infection. Even foals with some protection following partial FPT have only a 50% chance of resisting invaders such as Anaplasma, Giardia and Cryptosporidium.
The new-born foal’s absorption of maternal antibodies is most efficient in the first 6 to 8 hours of life, effectively ceasing after 24 to 36 hours. Veterinary surgeons and managers of equestrian facilities have only this narrow window to recognise FPT and act to save a valuable new-born from life threatening infection.
Mike added: "With Fastest Equine as part of their field kit, equine vets are equipped to diagnose and treat antibody deficient foals with life-saving colostrum, colsotrum formula substitute, or administer oral or intravenous IgG, within that critical first 24 hours."
The group is hoping to raise more than £5,000 for the hospital by donating £1 for every pet vaccinated at its West Derby, Gateacre, St Helens and Widnes practices over the next four months.
Sarah Kirkman MRCVS, from White Cross Vets in Gateacre, said: "It’s our job to care for pets, but we also really care about the communities in which we operate, and we have a real affinity with the hospital. This partnership means we’re protecting pets, by vaccinating them against a wide range of nasty diseases, as well as raising money to support the invaluable work that the hospital does."
Allan Eves from Alder Hey Children’s Charity said: "We care for over 275,000 children, young people and their families treating everything from common illnesses to highly complex and specialist conditions. We also lead research into children’s medicines, infection, inflammation and oncology and our charity has raised over £22m to support Alder Hey Children’s Hospital, funding life-saving medical equipment, research and vital facilities. We are so pleased to be working with White Cross Vets on this superb fund-raising initiative and can’t wait to meet the vets and nurses who are helping us."
Sarah added: "We are aiming to raise £5,000, but it could be more. We also want to support the hospital’s therapy dog by providing them with our Complete Wellness Plan for free. The plan provides free health-checks, veterinary care and preventative treatment on an ongoing basis. We already give free membership to several Fire Service Search Dog Teams, as we feel it’s really important to look after these amazing dogs which dedicate their lives to help people."
The charitable campaign is running from the 4th September until the 31st December and plans are also in place for the veterinary surgeons and nurses from White Cross Vets to visit the hospital regularly to talk to the children about pets.
Sarah said: "We give every one of our team four paid donation days a year, so that they can volunteer with a charity of their choice, and we are keen to further our partnership with the hospital by visiting regularly. We already do this in numerous schools across the region and know just how much children love to find out about our day to day roles, and they always have plenty of interesting questions for our nurses and vets to answer."
Defra has announced plans to form a new Animal Health and Welfare Board for England which will bring experts including farmers, veterinary surgeons, welfare experts and others from outside Government together with the Chief Veterinary Officer and civil servants to make direct policy recommendations on policy affecting the health and welfare of all kept animals such as farm animals, horses and pets.
According to Agriculture Minister Jim Paice, it is the first time that people affected by Government policy on animal health and welfare will make recommendations on those policies directly to Ministers.
Mr Paice said: "This is a completely new way of working. It replaces the old ways, where the people most affected by decisions were kept at arm's length from policy making on those subjects.
"This is about the Big Society not just existing in our communities, but in the heart of Government - helping to put the decisions in the hands of those who are doing the work on the ground.
"We've already seen the success of a partnership between farmers and the Government with the work that's been done on bluetongue - which has seen the disease virtually eradicated in this country."
Final decisions on animal health and welfare policy will remain in the hands of Government Ministers.
The Board will be made up of around 12 members, 5 senior Defra officials including the Chief Veterinary Officer, and 7-8 external members including the chair. The external members will have experience and knowledge of kept and farmed animals, animal and veterinary science, and animal welfare, and could be farmers, veterinarians, animal welfare experts.
The Board and its members will have to represent the views of all stakeholders so will be expected to communicate with them regularly.
The Board's responsibilities will include:
The Board will not be set up as a non departmental public body or arms length body. It will form part of the internal structure of Defra.
Commenting on the announcement, Harvey Locke, President of the British Veterinary Association, said: "The BVA is delighted that both the Advisory Group and Ministers have taken note of the veterinary profession's views in drawing up these plans.
"We said from the outset that genuine responsibility sharing has to be achieved before cost sharing can be discussed and we warned against earlier plans to separate animal health policy from animal welfare policy, as the two are intrinsically linked.
"Animal health and welfare policy issues require expert, scientific input and it will be essential that the new Board includes veterinary representation. We believe that the Board will provide the right mechanism for ensuring decisions are based on sound science.
"The new Board will also have to work closely with the three devolved administrations to ensure that animal health and welfare policies across the UK are joined up and complementary."
The RCVS Disciplinary Committee has dismissed a case against a Kent veterinary surgeon convicted of tail-docking and also charged with misleadingly altering an owner's record relating to tail dockings.
At the outset of the four-day hearing, David Smith, of Lakeview Veterinary Centre, Deal, admitted he had been convicted of an offence of tail docking on 14 December 2010 at the Channel Magistrates Court.
He said that, in 2008, he had misinterpreted the legislation about tail docking and as a result had removed the tails of a litter of 13 Rottweiler puppies. He was subsequently convicted of illegal docking.
Mr Smith also accepted he had altered the owner's record, at the owner's request, when the RSPCA was investigating the circumstances of the docking by adding the words "for law enforcement", but maintained this alteration was to clarify the record to which he had initially added the words "for security selection"; he denied any attempt to mislead, or that he ought to have known it may mislead.
The Committee accepted that Mr Smith misinterpreted the legislation and had taken some steps to satisfy himself that the tail docking was legal, namely: he had asked an employee colleague to make enquires of the College and, as advised, he had downloaded a copy of the AWA 2006 to read and to make his own decision with regard to legality; some enquiry had been made by the practice of the Department for Environment, Food and Rural Affairs (Defra) at Reigate; and, Mr Smith had himself researched dog breeds on the Kennel Club website.
The Committee also accepted that he had asked and been told that the client had previously supplied dogs to the police.
However, the Committee found that these steps were inadequate; in particular, he should have contacted the College and Defra himself and not delegated this to administrative staff. Furthermore, that he should have obtained confirmation of the advice given in writing.
Regarding the alteration of the owner's record, the Committee was satisfied that this annotation was added for clarification. The Committee was not satisfied that the addition 'for law enforcement' altered the meaning of what was already stated on this form, and found the wording confirmed Mr Smith's misapprehension at the time of the legality of the tail docking.
This charge, which alleged that the alteration had been carried out misleadingly, was dismissed.
The Committee also said that Mr Smith's reluctance to engage with the police and the RSPCA during their later investigation had been regrettable: as a professional he had had a duty to co-operate fully. However, it concluded that this had been "of little probative significance".
The Committee would like to make it clear that it is the responsibility of every practising veterinary surgeon to ensure that tail docking is legal in each and every instance before carrying out the procedure. If there is any doubt, then tail docking should not take place.
In deciding whether Mr Smith was fit to practise, the Committee took into account two previous RCVS Disciplinary Committee findings involving tail-docking.
It concluded these were significantly different. In the first case, the respondent knew that the tail docking he had carried out was illegal. On the contrary Mr Smith had misguidedly believed the docking he carried out was permitted.
In the second case there had been several charges, in addition to the charge of tail docking. In this case no charges other than those related to tail docking had been alleged against Mr Smith.
It further noted that no issues of clinical competence were raised, and that the dockings were undertaken less than 12 months after the new legislation came into force.
Speaking on behalf of the Committee, Vice-Chairman Beverley Cottrell, who chaired the hearing, said: "The Committee has expressed its disapproval about Mr Smith's failure to make adequate investigations of the College and of Defra, and his erroneous interpretation of the Act.
"In reaching its decision, the Committee has paid particular attention to issues of animal welfare, maintaining public confidence in the profession and the upholding of proper standards of conduct.
It has concluded that Mr Smith's conduct fell short of that to be expected of a veterinary surgeon but does not consider that it fell far short."
After directing that the case should be dismissed, Mrs Cottrell added: "The Committee would like to make it clear that it is the responsibility of every practising veterinary surgeon to ensure that tail docking is legal in each and every instance before carrying out the procedure. If there is any doubt, then tail docking should not take place."
The refreshed packaging keeps the same colour scheme, but the graphics indicating the product uses stand out better.
The company has also added an area on the side of the carton for owners to note the date each dose is given.
What can I say, it's a slow news day.
Next week, Princess Anne will unveil a new life-sized bronze of the Household Cavalry horse Sefton at the Royal Veterinary College in North Mymms, Hertfordshire.
The statue of Sefton is sited outside the College's Teaching and Research Centre, standing on the footprint of the former Sefton Equine Hospital, a facility which has now been relocated to a new Equine Referral Hospital on campus.
Sefton suffered terrible injuries in the Hyde Park bombing of July 1982 in which four men and seven horses died. In the aftermath of the bombing, as the most severely injured horse, his story of recovery captured the nation's hearts and the horse came to symbolise the resilience that is characteristic of the armed forces.
Many who knew and rode Sefton have provided the detailed briefings necessary for the sculptor, Camilla Le May, to capture the character and spirit of a great horse. Camilla said: "It was fascinating to talk to those who rode and knew Sefton well and this, along with studying old photos, enabled me to find out some of his individual traits such as the way he often tilted his head, looking back over his shoulder, which I chose to represent in this work. He was by all accounts a strong character and quite a handful, especially in his youth. Perhaps it was partly this strength of character that helped him pull through his appalling injuries."
Professor Josh Slater, head of the equine clinical group at the RVC, said: "The College has a proud tradition of furthering care and developing innovative treatments through dedicated equine veterinary surgeons and nurses. We were proud to have received a grant from The Horse Trust in 1986 to build our former equine hospital in Sefton's memory. Whilst we may have moved our practice to bigger and better facilities this new statue will serve as a reminder of the bravery and resilience of Sefton that inspired so many."
The new statue was commissioned to recognise and honour the life-time achievements of one of the College's longest servicing senior academics Professor Peter Lees, who retired in 2010. It was funded by RVC Honorary Fellow and Chairman of Norbrook Lord Ballyedmond OBE.
Professor Stuart Reid, Principal at the RVC, said: "I would like to thank the generosity of our friend Lord Ballyedmond for his kind donation in recognition of our esteemed colleague Professor Lees that has enabled us create this statue in memory of a great horse."
The new service is being headed by Dr Katia Marioni-Henry.
Katia graduated from the University of Parma in 1995 and went on to do a PhD in Clinical Electrodiagnostic at the University of Turin and Scott-Ritchey Research Center in Auburn, Alabama.
Her early career was spent at various American universities, where she became a Diplomate of the American College of Veterinary Internal Medicine, with a subspecialty in Neurology and finally an Assistant Professor of Neurology and Neurosurgery at the University of Tennessee.
Katia came to the UK to work as a consultant in neurology and neurosurgery for a number of large referral practices, before moving to the University of Edinburgh in 2013, where she started the neurology/neurosurgery service, building it from scratch to a nine-strong team.
Katia said: “This is absolutely the best place to be brought in an emergency, but previously we’d have to refer some cases elsewhere for conditions affecting the brain, peripheral nerves or the spine.
“Now some of these debilitating neurological conditions can be diagnosed and treated rapidly here without having to transport the animal.”
“With our CT scanner, for example, we can diagnose slipped discs quickly, especially in small breeds, and treat them surgically.
“And we can use it for brain scans if there is trauma or if we suspect a tumour or severe inflammation in the brain.
“We can do a lumbar tap to rule out inflammation of the central nervous system either on infectious or immune-mediated basis.”
The company says AI Masses will allow veterinary professionals to analyse lesions suggestive of cancer in-clinic and with a fast turnaround.
The AI technology, which has been trained by human clinical pathologists, should enable individualised treatment outcomes earlier for more cases.
Zoetis says AI Masses only needs a single round of sample preparation and the results can, at additional cost, be supplemented with an expert review from a network of specialists through Zoetis’ Virtual Laboratory.
Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA, Global Chief Medical Officer at Zoetis said: “Waiting for results can be stressful for pet owners – even more so when it involves a cancer screening.
"Our research shows that up to 75% of pet owners find abnormal results highly stressful.1
"AI Masses is yet another point-of-care capability to deliver results in-clinic, further exemplifies Zoetis’ purpose to advance care for animals, shortening anxious wait times to allow for faster care decisions that help provide the best possible outcome.”
Pre-orders will be announced for US customers in Q2 2025.
VetSurgeon.org understands AI Masses will be coming to the UK some time in 2025.
https://www.zoetisdiagnostics.com
Reference
Companion Care Vets has opened its first new standalone joint venture surgery in Ayr, Scotland.
At 3,071 sq ft the £300,000 surgery is the largest of the groups' 86 strong network and is the first standalone surgery to be opened under the joint venture partnership model that has been in place since 2001.
The surgery is located in a retail park environment, to give easy access for clients and their pets. It is a full service practice, which Companion Care says is fitted with all the latest equipment, including digital x-ray machines and a full operating suite.
Managing Director, Jane Balmain, said: "The opening of our first new standalone surgery in Ayr is a real milestone for us as a business because it opens up our offering to the vets and veterinary nurses who are interested in a joint venture partnership, but whose preference is to have a more traditional looking standalone surgery."
Whilst the Ayr surgery is standalone in its own right, due to the unique relationship Companion Care Vets has with Pets at Home, the surgery works in close partnership with the local Pets at Home store. This will help to drive client registrations and business development and further enable Pets at Home to develop the full pet care experience for its customers.
Jane added: "We believe that this new venture offers any potential partner the best of both worlds: a superb in-store surgery with footfall of thousands of customers a month, or a standalone new surgery linked to local store network to develop the business. I don't believe any other company can offer this unique proposition."
Veterinary surgeon, and joint venture partner of the Ayr surgery, Kirstin Fyfe says, "I am extremely proud to be opening the first standalone surgery alongside the Companion Care team and the facilities available to my team and I and local pet owners are fantastic. The latest equipment, coupled with a spacious and modern waiting area and the convenience of our location is what makes this a winning formula."
Petplan has announced the finalists for the 2012 Petplan Veterinary Awards.
According to the company, the awards have been more popular than ever, with over 3,000 nominations submitted for exceptional veterinary staff across the UK.
The finalists for each of the categories are:
Vet of the YearZaila Dunbar, Queens Park Veterinary Practice - London Tony Barnes, Manor Veterinary Clinic - FolkestoneMark Taylor, Feldon Veterinary Centre - Bedworth
Vet Nurse of the YearLucy Kells, The Wildlife Aid Foundation - LeatherheadRachael Harris, Elms Veterinary Surgery - MonmouthSarah Algar, Brentknoll Veterinary Centre Ltd - Worcester
Support Staff of the YearSarah Bowler, Holly House Veterinary Surgery - KnutsfordJane Wyatt, George Hunt and Son - PoyntonCathy Campbell, Haygate Veterinary Centre - Telford
Vet Practice of the YearEastcott Veterinary Clinic and Hospital - SwindonPrince Bishop Veterinary Hospital - County DurhamBroadleys Veterinary Hospital - Stirling
Simon Masding, Petplan's Head of Sales and Partnerships, said: "The Vet of the Year Awards are the highlight of our Petplan calendar because they recognise the dedication that the veterinary industry puts into providing the nation's pets with the best possible treatment. Each year the nominations reach an even higher standard and we're delighted with this year's finalists. At Petplan we work with more veterinary professionals than any other insurance provider and it is through these awards that we thank the profession on behalf of UK pet owners."
Petplan has also announced that comedian Seann Walsh, known for his appearances on shows like Mock the Week and Michael McIntyre's Comedy Roadshow, will be this year's compère for the Vet of the Year Awards. Following in the footsteps of previous compères Michael McIntyre, Alistair McGowan, Frankie Boyle and Jason Manford; he will be entertaining this year's guests on the 12th April at Birmingham Town Hall.
For further information visit www.petplan.co.uk/vetawards/
Animalcare Ltd has launched Marbocare (marbofloxacin) 100mg/ml solution for injection, a third-generation fluoroquinolone for the treatment of E.coli mastitis and bovine respiratory disease (BRD) in cattle, and Metritis Mastitis Agalactia in pigs.
The company highlights the product's unique flexible dosage regimen of once daily injections for 3 days against E.coli mastitis and BRD, plus a single intramuscular (IM) high dose (8mg/100kg) for BRD.
Animalcare says this regimen, coupled with the flexibility of administration afforded by all three injection routes (intravenous IV, subcutaneous SC and IM), a low volume dose and good syringeability, all combine to offer ease of use; resulting in a reduction in handling and less stress for the cattle.
Developed for veterinary use only, Marbocare has broad spectrum activity against Gram+ve and Gram-ve pathogens. Animalcare says the product is especially effective against E.coli mastitis and the key bacterial pathogens associated with BRD, as well as M.bovis.
Marbocare has milk withdrawal times of 36 hours after the last treatment following the 3 day course and 72 hours after a single shot for BRD. Meat withdrawal is 6 days after multiple injections and 3 days after the single shot.
Marbofloxacin has proven efficacy in a comparative international, multi-centre, controlled, randomised field trial1 in 62 dairy cows with E.coli mastitis. Marbofloxacin cure rates were significantly higher than the control product. In respiratory disease it showed a more rapid clinical response in comparison to tilmicosin2, ceftiofur3 and oxytetracycline4. Marbofloxacin was shown to be well tolerated, leading to a fast return to appetite, liveweight gain and associated welfare benefits.
Marbocare is also licensed in the treatment of Metritis Mastitis Agalactia syndrome in pigs, given by IM injection, with a 4 day meat withdrawal.
Tony Liepman, Product Manager from Animalcare said: "Marbocare is competitively priced whether used on its own or alongside a single-dose anti-inflammatory such as Emdocam (meloxicam)."
Marbocare is a POM-V licensed product presented in 50 and 100ml multi-dose vials.
References
Gerry, who joined North Downs in 2008, has been clinical director at the hospital since 2012.
He has published scientific literature and lectured across the world on a range of cancer subjects including lymphoma, mast cell tumours, lung tumours, insulin-producing tumours and novel anti-cancer therapies.
He also chairs and participates in a number of European oncology research projects and has a particular interest in collaborative clinical research.
Gerry said: “I’m delighted to be taking on this role, working alongside an incredibly talented and committed team.
“NDSR has achieved so much over the years, not only with cutting-edge treatments and procedures, but also with the implementation of an innovative new nursing structure, an industry-leading internship programme and being among the first veterinary hospitals to achieve a Green iiE award, to name just a few.
Talking about his main aims for the new role, Gerry said: “I want to create opportunities for our amazing team to develop into leadership roles, giving more autonomy to individual services and improving communication between services and management.
“From a care quality perspective, we always want to improve, and I look forward to harnessing innovative ideas and tools that might lead to better outcomes for pets and their families.
https://www.ndsr.co.uk.
The research is being carried out by XLChief Operating Officer Kerrie Hedley, building on work she carried out last year which she talks about in a podcast currently hosted on the Veterinary Women website.
Female vets who would like to take part in the research, whether or not they are business owners, are invited to email Kerrie at kerrie.hedley@xlvets.co.uk.
Kerrie says she wants to ensure she hears a wide variety of viewpoints: “If women are averse to leadership or doubtful about the benefits of leadership, they should be heard too. There’s a great deal of support and momentum behind this project within the XLVets community and it’s something we all think is hugely important for the future of the profession. We had a tremendous response to our last call for participants and I’m looking forward to gaining more insight into this important topic and helping to develop innovative solutions.”
Developed in partnership with the Veterinary Client Mediation Service (VCMS), the course uses practical examples based on real-life experiences.
The course shows how to assess complaints from a client’s perspective and how building client relationships can help defuse complaints.
Jennie Jones, Head of VCMS, said: "Leveraging insights from the VCMS and involving our entire team with its production has enabled us to develop highly effective materials that ensure veterinary professionals are well-equipped to manage complaints."
The course takes one hour to complete.
academy.rcvs.org.uk
The new hospital, which is led by a large team of internationally-renowned Specialists, supported by residents, interns and registered veterinary nurses, will over time employ over 100 veterinary professionals.
CVS says the site will offer the latest technology and treatments in all small animal disciplines including: general surgery, orthopaedics, neurology and neurosurgery, internal medicine, ophthalmology, cardiology, dermatology, oncology and dentistry, as well as dedicated anaesthesia, analgesia, diagnostic imaging and intensive care departments.
There will be a multi-disciplinary approach, with a team around every patient, to ensure the best outcome for the animal.
CVS says BVS's oncology department, with its stereotactic linear accelerator for radiotherapy, will offer most advanced cancer treatment for cats and dogs in Europe.
The site also has the latest CT and MRI scanners and a separate feline unit.
On arrival, clients are taken to a special customer experience zone by a dedicated client liaison officer to ensure their pet is comfortable and they are fully informed about their procedure.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our advanced facilities and eminent colleagues will mean we can provide the best animal care to pet owners across the South West, and we have invested in cutting-edge technology to bring cancer treatment in pets to the next level.
"So we know that this site will become as a centre of excellence in the veterinary world.”
https://www.bristolvetspecialists.co.uk